Phase I/II study of triweekly administration regimen of irinotecan and TS-1 in patients with advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Treatment : TS-1+CPT-11 Primary outcome(s): 1) Phase I To determine the recommended dose 2) Phase II Response Rate Study Design: Single arm Non-randomized
创建时间：
2004-12-15
